<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-7T342Y3O</identifier><date>2017</date><creator>Gmeiner, Tanja</creator><creator>Kolenc-Peitl, Petra</creator><creator>Krošelj, Marko</creator><creator>Leskovec, Marijana</creator><creator>Mlinarič-Raščan, Irena</creator><creator>Sočan, Aljaž</creator><relation>documents/doc/7/URN_NBN_SI_doc-7T342Y3O_001.pdf</relation><relation>documents/doc/7/URN_NBN_SI_doc-7T342Y3O_001.txt</relation><format format_type="volume">87</format><format format_type="issue">9/10</format><format format_type="type">article</format><format format_type="extent">Str. 439-452</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID_HOST">5389996</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-7T342Y3O</identifier><language>eng</language><publisher>Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">minigastrin</subject><subject language_type_id="slv">radiofarmaki</subject><subject language_type_id="slv">radiooznačeni peptidi</subject><subject language_type_id="slv">somatostatin</subject><subject language_type_id="slv">teranostiki</subject><title>Radiooznačeni peptidi v nuklearni medicini</title><title>Radiolabelled peptides in nuclear medicine</title></Record>